Latest Medtech News
Mosaic Intelligence Labs, a San Francisco company, has come out of stealth with $47 million in seed funding from investors including 8VC, Fundomo, Lingotto Innovation and Obvious Ventures. The company is building sensing-enabled spatial intelligence and robotic infrastructure to help physicians navigate the body from within, starting with endovascular procedures, in which flexible wires and catheters are guided through blood vessels.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.
Today, physicians working inside vessels have no direct line of sight. They combine live X-ray images, preoperative scans and the feel of the instrument, and reading those signals takes years of practice. Mosaic puts sensing where instruments meet anatomy and uses computation to reconstruct the vessel from within. The platform is designed to give physicians a continuously updated 3D picture of anatomy and instrument position, paired with a robotic interface for precise control.
CEO Dr. Ileana Pirozzi framed the aim as a question: “what would it take to scale the knowledge of the very best surgeons?” Her co-founder and CTO, Dr. Alison Mackanic, points out that today’s instruments have no loop between perception and action, which limits what they can learn. The two met during their doctoral studies at Stanford.
For the broader MedTech space, the launch comes as investors back robotic and AI guidance in cardiovascular procedures, including GE HealthCare’s up to $160 million Series B in Laza Medical this month.
